P1086 (DAIDS ID 10835): A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Swine-Origin H1N1 Influenza Vaccine in HIV-1-Infected Pregnant Women

Study Status Study Restriction

Concluded

United States

What is P1086?

P1086 was a multi-center, Phase II, open label study of an inactivated Influenza A (H1N1) 2009 monovalent vaccine.  The study was designed to determine the safety and antibody response after each of two doses of Influenza A (H1N1) 2009 Monovalent Vaccine in HIV-1 infected pregnant women.

Study Documents:

Sites where the study was implemented:

CRS ID Site Name City Country

5011

Boston Medical Center Pediatric HIV Program

Boston

United States of America

5083

Rush University Cook County Hospital Chicago NICHD CRS

Chicago

United States of America

Study contacts:

No records returned.

CTS: IMPAACT Operations Center

 

Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.